Clinical Trial Update: Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating sodium bicarbonate to prevent contrast-induced nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy
• Kidney Injury

Drugs mentioned

• Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: Kaiser Permanente | Conditions: Contrast Induced Nephropathy, Kidney Diseases | Phase 3 | Status: COMPLETED